Рет қаралды 135
Step 1 is Drug/Gene Therapy Development
HNF works with our TRIAD partners, including innovative biotech, pharma, and award-winning researchers, to fund and support the most promising scientific approaches to potential treatments. In 2023, we conducted Repurposed Drug Screenings for 10 subtypes of CMT, and accomplished 9 potential Drugs for three CMT subtypes. We continue to advance our gene therapy program for 2 subtypes of CMT.
Learn more and watch our 4-part videos!
www.hnf-cure.o...